Our findings suggest that SIRT3 may block heart hypertrophy by inhibiting lipid metabolism disorders and attenuate lipid accumulation in the heart mitochondria through the deacetylation of LCAD. The gene discussed is SIRT3; the disease is cardiac hypertrophy.